Insider Trading activities of Arrhythmia Research Technology Inc /de/ insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arrhythmia Research Technology Inc /de/ since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arrhythmia Research Technology Inc /de/ since year 2005. Table 2 shows the detailed insider transactions of Arrhythmia Research Technology Inc /de/ since 2005. The reporting company's ticker symbol is HRT. The reporting company's CIK number is 819689.
The total value of stock buying since 2005 is $967,132.
The total value of stock sales since 2005 is $2,501,081.
The total value of stock option exercises since 2005 is $76,725.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Arrhythmia Research Technology Inc /de/ (HRT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-12 1,400 $5,185 0 $0 0 $0
2016-05 500 $1,900 0 $0 0 $0
2016-03 2,860 $11,212 0 $0 0 $0
2016-01 0 $0 0 $0 15,000 $51,150
2015-12 1,000 $3,410 0 $0 7,500 $25,575
2015-08 68,644 $438,160 13,940 $81,089 0 $0
2015-06 43,720 $284,132 1,172 $7,739 0 $0
2014-08 0 $0 18,000 $130,154 0 $0
2012-12 10,000 $25,920 0 $0 0 $0
2011-12 3,195 $11,544 0 $0 0 $0
2011-11 2,300 $7,797 0 $0 0 $0
2011-09 6,700 $25,142 0 $0 0 $0
2011-08 8,300 $31,136 0 $0 0 $0
2011-06 300 $1,455 0 $0 0 $0
2009-09 5,000 $15,464 0 $0 0 $0
2009-08 5,000 $16,371 0 $0 0 $0
2008-12 2,500 $6,180 0 $0 0 $0
2008-09 7,700 $35,903 0 $0 0 $0
2007-08 5,000 $46,221 8,000 $104,144 0 $0
2007-03 0 $0 12,216 $260,307 0 $0
2006-12 0 $0 71,490 $1,917,648 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Arrhythmia Research Technology Inc /de/ insiders (HRT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-12-16 Emma Salvatore Jr (CEO/President) Buy 1,400 3.70 5,185
2016-05-17 Benedetti Marco (Director) Buy 500 3.80 1,900
2016-03-16 Welch Derek Thomas (CFO) Buy 360 4.09 1,472
2016-03-15 Emma Salvatore Jr (CEO/President) Buy 2,500 3.90 9,740
2016-01-04 Walter Paul (Director) Option Ex 7,500 3.41 25,575
2016-01-04 Marinos E P (Director) Option Ex 7,500 3.41 25,575
2015-12-28 Emma Salvatore Jr (CEO/President/Director) Buy 1,000 3.41 3,410
2015-12-28 Chambers Jason Russell (Director) Option Ex 7,500 3.41 25,575
2015-08-31 Friedman Rodd (10% Owner) Buy 46,111 6.45 297,415
2015-08-31 Friedman Rodd (10% Owner) Sale 13,340 5.80 77,372
2015-08-31 Ref Securities & Co. (10% Owner) Sale 200 6.19 1,238
2015-08-28 Ref Securities & Co. (10% Owner) Buy 13,600 6.25 85,000
2015-08-28 Ref Securities & Co. (10% Owner) Sale 200 6.20 1,240
2015-08-24 Friedman Rodd (10% Owner) Buy 2,133 6.21 13,245
2015-06-16 Friedman Rodd (10% Owner) Buy 400 6.38 2,552
2015-06-15 Emma Salvatore Jr (President and CEO) Buy 22,210 6.50 144,365
2015-06-11 Chambers Jason Russell (Director) Sale 100 6.50 650
2015-06-10 Chambers Jason Russell (Director) Sale 1 6.50 6
2015-06-05 Chambers Jason Russell (Director) Sale 21 6.60 138
2015-06-04 Chambers Jason Russell (Director) Sale 900 6.60 5,940
2015-06-03 Chambers Jason Russell (Director) Sale 150 6.70 1,005
2014-08-19 Emma Salvatore Jr (PRESIDENT and CEO) Sale 8,600 7.19 61,816
2014-08-18 Emma Salvatore Jr (PRESIDENT and CEO) Sale 4,400 7.24 31,838
2014-08-14 Chambers Jason Russell (Director) Sale 5,000 7.30 36,500
2012-12-18 Gunter Michael S (Interim CEO) Buy 3,329 2.60 8,655
2012-12-17 Gunter Michael S (Interim CEO) Buy 1,671 2.65 4,428
2012-12-06 Gunter Michael S (Interim CEO) Buy 4,300 2.60 11,158
2012-12-05 Gunter Michael S (Interim CEO) Buy 600 2.40 1,440
2012-12-03 Gunter Michael S (Interim CEO) Buy 100 2.39 239
2011-12-13 Gunter Michael S (Director) Buy 500 3.20 1,600
2011-12-08 Muldoon Patrick L (Director) Buy 2,695 3.69 9,944
2011-11-29 Gunter Michael S (Director) Buy 2,300 3.39 7,797
2011-09-15 Rouse James E (President & CEO) Buy 5,000 3.81 19,065
2011-09-14 Gunter Michael S (Director) Buy 1,700 3.58 6,077
2011-08-30 Garrison David A (Executive VP & CFO) Buy 700 3.68 2,576
2011-08-29 Garrison David A (Executive VP & CFO) Buy 2,100 3.77 7,935
2011-08-26 Garrison David A (Executive VP & CFO) Buy 4,800 3.75 18,000
2011-06-13 Gunter Michael S (Director) Buy 300 4.85 1,455
2009-09-15 Garrison David A (Chief Financial Officer) Buy 2,200 3.06 6,723
2009-09-14 Garrison David A (Chief Financial Officer) Buy 2,800 3.12 8,741
2009-08-12 Garrison David A (Chief Financial Officer) Buy 2,250 3.35 7,530
2009-08-11 Garrison David A (Chief Financial Officer) Buy 2,750 3.21 8,841
2008-12-10 Marinos E P Buy 2,500 2.47 6,180
2008-09-15 Chambers Jason Russell Buy 6,800 4.67 31,769
2008-09-12 Chambers Jason Russell Buy 200 4.66 932
2008-09-11 Chambers Jason Russell Buy 700 4.58 3,202
2007-08-24 Rouse James E Sale 8,000 13.02 104,144
2007-08-21 Chambers Jason Russell Buy 2,100 9.25 19,425
2007-08-16 Chambers Jason Russell Buy 2,900 9.24 26,796
2007-03-19 Chambers Medical Foundation Sale 1,716 22.85 39,205
2007-03-15 Chambers Medical Foundation Sale 5,500 21.06 115,852
2007-03-13 Chambers Medical Foundation Sale 5,000 21.05 105,250
2006-12-08 Chambers Medical Foundation (10% Owner) Sale 12,500 26.70 333,700
2006-12-08 Rouse James E (President & CEO) Sale 6,000 26.50 159,000
2006-12-06 Chambers Medical Foundation (10% Owner) Sale 18,990 26.66 506,216
2006-12-05 Chambers Medical Foundation (10% Owner) Sale 31,000 27.07 839,232

Insider trading activities including stock purchases, stock sales, and option exercises of HRT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arrhythmia Research Technology Inc /de/ (symbol HRT, CIK number 819689) see the Securities and Exchange Commission (SEC) website.